FDA Inspection
Niagara Pharmaceuticals IncNiagara Pharmaceuticals Inc – FDA Inspection, Sep 18, 2017
Record Details
This FDA Inspection record concerns Niagara Pharmaceuticals Inc, with an inspection on September 18, 2017, issued by the Center for Drug Evaluation and Research, covering drugs.
View Company Profile
ID · 66c14af1-385f-46bf-b8c7-860b8a30d1db
Inspection Facts
No Action Indicated (NAI)
No objectionable conditions or practices were found during the inspection.
- Inspection number
- 1031416
- FDA center
- Human Drugs
- Project area
- Drug Quality Assurance
Other FDA inspections of Niagara Pharmaceuticals Inc
5| Date | Classification | Office | Project area |
|---|---|---|---|
| April 25, 2022 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| February 7, 2020 | OAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 16, 2016 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| May 14, 2014 | NAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
| September 8, 2010 | VAI | Center for Drug Evaluation and Research | Drug Quality Assurance |
Other documents for Niagara Pharmaceuticals Inc
Document or profile
One record shows the event. A profile shows the pattern.
Buy this document for the source file and details behind this single event.
Choose full profile access to connect related records, sites, people, citations, and enforcement history in one view.